Clinical Trial Update: A Study to Assess the Safety and Efficacy of Centhaquine in Hypovolemic Shock Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is assessing the safety and efficacy of Centhaquine in patients with hypovolemic shock; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemic Shock

Drugs mentioned

• Centhaquine (Centhaquine)

Snippet

Sponsor: Pharmazz, Inc. | Conditions: Hypovolemic Shock | Phase 4 | Status: RECRUITING